<i>APC</i> and <i>P53</i> mutations synergize to create a therapeutic vulnerability to NOTUM inhibition in advanced colorectal cancerYuhua Tian(Tianjin University of Traditional Chinese Medicine), Ning Li(University of Pennsylvania)bioRxiv (Cold Spring Harbor Laboratory)July 27, 202210.1101/2022.07.26.501557Cited by 0SaveCiteExport RISWatch citationsRelated PapersMapping and modeling human colorectal carcinoma interactions with the tumor microenvironment|Nature Communications|2023|62Dll1-Mediated Notch Signaling Drives Tumor Cell Cross-talk with Cancer-Associated Fibroblasts to Promote Radioresistance in Breast Cancer|Cancer Research|2022|37